Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Leases (2023 - 2025)

Historic Leases for bioAffinity Technologies (BIAF) over the last 3 years, with Q3 2025 value amounting to $565030.0.

  • bioAffinity Technologies' Leases fell 5634.03% to $565030.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $565030.0, marking a year-over-year decrease of 5634.03%. This contributed to the annual value of $1.3 million for FY2024, which is 0.0% changed from last year.
  • bioAffinity Technologies' Leases amounted to $565030.0 in Q3 2025, which was down 5634.03% from $565030.0 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Leases peaked at $1.3 million during Q3 2023, and registered a low of $565030.0 during Q2 2025.
  • For the 3-year period, bioAffinity Technologies' Leases averaged around $1.1 million, with its median value being $1.3 million (2023).
  • In the last 5 years, bioAffinity Technologies' Leases changed by 0.0% in 2024 and then tumbled by 5634.03% in 2025.
  • Quarter analysis of 3 years shows bioAffinity Technologies' Leases stood at $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then plummeted by 56.34% to $565030.0 in 2025.
  • Its Leases stands at $565030.0 for Q3 2025, versus $565030.0 for Q2 2025 and $1.3 million for Q1 2025.